Back to Search Start Over

Concurrent bacterial endocarditis is associated with worse inpatient outcomes for large vessel occlusions.

Authors :
Ramsay IA
Elarjani T
Govindarajan V
Silva MA
Abdelsalam A
Burks JD
Starke RM
Luther E
Source :
Journal of neurointerventional surgery [J Neurointerv Surg] 2024 Jun 17; Vol. 16 (7), pp. 657-662. Date of Electronic Publication: 2024 Jun 17.
Publication Year :
2024

Abstract

Background: Neurological complications of bacterial endocarditis (BE) are common, including acute ischemic stroke (AIS). Although mechanical thrombectomy (MT) is effective for large vessel occlusion (LVO) stroke, data are limited on MT for LVOs in patients with endocarditis. We assess outcomes in patients treated with thrombectomy for LVOs with concurrent BE.<br />Methods: The National Inpatient Sample (NIS) was used. The NIS was queried from October 2015-2019 for patients receiving MT for LVO of the middle cerebral artery. Odds ratios (OR) were calculated using a multivariate logistic regression model.<br />Results: A total of 635 AIS with BE patients and 57 420 AIS only patients were identified undergoing MT. AIS with BE patients had a death rate of 26.8% versus 10.2% in the stroke alone cohort, and were also less likely to have a routine discharge (10.2% vs 20.9%, both P<0.0001). AIS with BE patients had higher odds of death (OR 3.94) and lower odds of routine discharge (OR 0.23). AIS with BE patients also had higher rates of post-treatment cerebral hemorrhage, 39.4% vs 23.7%, with an OR of 2.20 (P<0.0001 for both analyses). These patients also had higher odds of other complications, including hydrocephalus, respiratory failure, acute kidney injury, and sepsis.<br />Conclusion: While MT can be used to treat endocarditis patients with LVOs, these patients have worse outcomes. Additional investigations should be undertaken to better understand their clinical course, and further develop treatments for endocarditis patients with stroke.<br />Competing Interests: Competing interests: The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Robert M Starke has consulting and teaching agreements with Penumbra, Abbott, Medtronic, InNeuroCo, and Cerenovus.<br /> (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1759-8486
Volume :
16
Issue :
7
Database :
MEDLINE
Journal :
Journal of neurointerventional surgery
Publication Type :
Academic Journal
Accession number :
37586820
Full Text :
https://doi.org/10.1136/jnis-2023-020381